Pro Stride

 

 

Pro Stride -APS (autologous protein serum) is an innovative autologous product derived from the patient’s own blood. It consists of concentrated plasma, leukocytes, anti-inflammatory proteins (including I-1ra and other anabolic proteins), and platelets enriched with growth factors.   

 

Using the patient’s own blood, the Pro-Stride APS dual device separates and concentrates these proteins (in a process that takes less than 20 minutes), so that the output can be injected during a single visit.

 

Interleukin-1, also known as IL-1, and tumor necrosis factor alpha, also known as TNF-alpha, are the key pro-inflammatory proteins called cytokines, which need to be blocked from damaging the tissue.  These inflammatory cytokines bind to the cell surface receptors on the cartilage and start the process of cartilage breakdown which ultimately leads to joint pain and damage.  

 

 

There are several naturally occurring inhibitors (anti-inflammatory proteins) of the pro-inflammatory cytokines IL-1 and TNF-alpha.  These include the interleukin-1 receptor antagonist protein (IRAP), also known as IL-1ra, SIL-1r, also known as soluble interleukin-1 receptor, and STNF-rs, known as soluble tumor necrosis factor receptors. All of these are highly concentrated within Pro-Stride APS. 

 

 

Benefits of Pro Stride: 

 

• Pro-Stride does not require an incubation period

• Pro-Stride's output is not an autologous conditioned serum (ACS)

• Pro-Stride's output is never frozen